Patent Application
App. No. 17/669,785
INHIBITORS OF RET
Loading inventors, assignments & file history…
Abstract
Described herein are compounds that inhibit wild-type RET and its resistant mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.
Claims (2)
1 - 19 . (canceled)
20 . A compound which is:
Assignments (7)
RELEASE OF SECURITY INTEREST (REEL/FRAME NUMBER 060616/0923)
Recorded Jul 23, 2025
From: TAO TALENTS, LLC
To: BLUEPRINT MEDICINES CORPORATION
Reel/Frame 072193/0847 →
SECURITY INTEREST
Recorded May 23, 2024
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 067509/0146 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 8, 2024
From: BLUEPRINT MEDICINES CORPORATION
To: RIGEL PHARMACEUTICALS, INC.
Reel/Frame 066703/0974 →
RELEASE OF SECURITY INTEREST
Recorded Feb 22, 2024
From: TAO TALENTS, LLC, AS ADMINISTRATIVE AGENT
To: BLUEPRINT MEDICINES CORPORATION
Reel/Frame 066536/0717 →
SECURITY INTEREST
Recorded Jul 8, 2022
From: BLUEPRINT MEDICINES CORPORATION
To: TAO TALENTS, LLC
Reel/Frame 060616/0923 →
ASSIGNEE CHANGE OF ADDRESS
Recorded May 27, 2022
From: BLUEPRINT MEDICINES CORPORATION
To: BLUEPRINT MEDICINES CORPORATION
Reel/Frame 060203/0900 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded May 27, 2022
From: BRUBAKER, JASON D.; KIM, JOSEPH L.; WILSON, KEVIN J.; WILSON, DOUGLAS; DIPIETRO, LUCIAN V.
To: BLUEPRINT MEDICINES CORPORATION
Reel/Frame 060389/0641 →